Cargando…

Detection and predictors of anti-SARS-CoV-2 antibody levels in COVID-19 patients at 8 months after symptom onset

Aim: To determine SARS-CoV-2 specific IgM and IgG levels of patients with COVID-19 at 8 months after symptom onset and to explore the predictors of antibody levels. Materials & methods: The magnetic chemiluminescence method was used to measure the antibody levels. Clinical data were collected an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jing, Li, Li, Wu, Qian, Li, Hongwei, Li, Yajie, Hou, Xinwei, Yang, Fangfei, Qin, Zhonghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596336/ https://www.ncbi.nlm.nih.gov/pubmed/34804188 http://dx.doi.org/10.2217/fvl-2021-0141

Ejemplares similares

Serum levels of laminin and von Willebrand factor in COVID-19 survivors 6 months after discharge
por: Li, Hongwei, et al.
Publicado: (2022)

A follow-up study of respiratory and physical function after discharge in patients with redetectable positive SARS-CoV-2 nucleic acid results following recovery from COVID-19
por: Wu, Qian, et al.
Publicado: (2021)

A Follow-Up Study of Lung Function and Chest Computed Tomography at 6 Months after Discharge in Patients with Coronavirus Disease 2019
por: Wu, Qian, et al.
Publicado: (2021)

Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection
por: Duncombe, Caroline J., et al.
Publicado: (2021)

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
por: Bylicki, Olivier, et al.
Publicado: (2021)

Syncope at SARS-CoV-2 onset
por: Canetta, Ciro, et al.
Publicado: (2020)

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
por: Perreault, Josée, et al.
Publicado: (2020)

Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients
por: Zhu, Liguo, et al.
Publicado: (2021)

SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort
por: Finch, Emilie, et al.
Publicado: (2022)

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
por: Anand, Sai Priya, et al.
Publicado: (2021)

Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms
por: Linares, Manuel, et al.
Publicado: (2020)

Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
por: Caronna, Edoardo, et al.
Publicado: (2021)

IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
por: Fernandes-Siqueira, Lorena O., et al.
Publicado: (2022)

IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: A Northern Ireland observational study
por: Robertson, Louise J., et al.
Publicado: (2022)

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
por: Van Elslande, Jan, et al.
Publicado: (2021)

Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset
por: Lou, Bin, et al.
Publicado: (2020)

Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients
por: Sejdic, Adin, et al.
Publicado: (2023)

Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge
por: Li, Hongwei, et al.
Publicado: (2022)

Symptoms in patients with asthma infected by SARS-CoV-2
por: Garcia-Pachon, Eduardo, et al.
Publicado: (2021)

SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain
por: Li, Jianhua, et al.
Publicado: (2023)

Tracking the onset date of the community spread of SARS-CoV-2 in western countries
por: Delatorre, Edson, et al.
Publicado: (2020)

Tear antibodies to SARS‐CoV‐2: implications for transmission
por: Selva, Kevin J, et al.
Publicado: (2021)

Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection
por: Huang, Zhi-Xin, et al.
Publicado: (2020)

Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection
por: Murillo-Zamora, E., et al.
Publicado: (2021)

REGEN‐COV antibody combination in patients with lymphoproliferative malignancies and SARS‐CoV‐2 infection
por: Bronstein, Yotam, et al.
Publicado: (2022)

Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2
por: Cortés-Borra, Albert, et al.
Publicado: (2021)

Assessment of commercial SARS-CoV-2 antibody assays, Jamaica
por: Butterfield, Tiffany R., et al.
Publicado: (2021)

Anxiety, depression, and PTSD symptoms among high school students in china in response to the COVID-19 pandemic and lockdown
por: Cao, Chengqi, et al.
Publicado: (2022)

Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
por: Xiang, Tiandan, et al.
Publicado: (2021)

A surviving 24-month-old patient with neonatal-onset carnitine palmitoyltransferase II deficiency
por: Ikeda, Naohiro, et al.
Publicado: (2017)

The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread
por: Bui, Ngoc-Niem, et al.
Publicado: (2021)

Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients
por: Levi, Riccardo, et al.
Publicado: (2021)

Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria
por: Lehmann, Jens, et al.
Publicado: (2021)

SARS‐CoV‐2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection
por: Li, Hua, et al.
Publicado: (2020)

Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody
por: Cao, Xiaoling, et al.
Publicado: (2022)

Duration of anti-SARS-CoV-2 antibodies much shorter in India
por: Kumar, Nishant, et al.
Publicado: (2021)

Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand
por: Whitcombe, Alana L, et al.
Publicado: (2021)

Long‐term persistence of neutralizing SARS‐CoV‐2 antibodies in pets
por: Decaro, Nicola, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1m1jdf5q52e5ic1sr72u2nu9lq